Page last updated: 2024-10-21

phenytoin and Diffuse Parenchymal Lung Disease

phenytoin has been researched along with Diffuse Parenchymal Lung Disease in 2 studies

Research Excerpts

ExcerptRelevanceReference
" He had complex partial seizures for the past 22 years, which had been well controlled on phenytoin (300 mg daily)."8.12Longstanding Phenytoin Use as a Cause of Progressive Dyspnea. ( Al Omari, O; Jani, C; McCannon, J; Patel, D; Perrino, C; Rupal, A; Singh, H; Walker, A, 2022)
" He had complex partial seizures for the past 22 years, which had been well controlled on phenytoin (300 mg daily)."4.12Longstanding Phenytoin Use as a Cause of Progressive Dyspnea. ( Al Omari, O; Jani, C; McCannon, J; Patel, D; Perrino, C; Rupal, A; Singh, H; Walker, A, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Walker, A1
Rupal, A1
Jani, C1
Al Omari, O1
Singh, H1
Patel, D1
Perrino, C1
McCannon, J1
Okamoto, H1
Ishimaru, T1
Ohgami, N1
Furugaki, K1
Emoto, T1
Ekimura, M1

Reviews

1 review available for phenytoin and Diffuse Parenchymal Lung Disease

ArticleYear
[A case of drug-induced interstitial pneumonia due to phenytoin].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:8

    Topics: Anticonvulsants; Female; Humans; Lung Diseases, Interstitial; Middle Aged; Phenytoin

2009

Other Studies

1 other study available for phenytoin and Diffuse Parenchymal Lung Disease

ArticleYear
Longstanding Phenytoin Use as a Cause of Progressive Dyspnea.
    Chest, 2022, Volume: 161, Issue:2

    Topics: Biopsy; COVID-19; Diagnosis, Differential; Drug Substitution; Dyspnea; Humans; Lacosamide; Lung; Lun

2022